Amgen (AMGN) r&d spend was $7.3B in FY2025 (+22% YoY). The tables below show the complete quarterly and annual r&d spend history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual R&D Spend
Fiscal Year
R&D Spend
YoY
2025
$7.3B
+22%
2024
$6.0B
+25%
2023
$4.8B
+8%
2022
$4.4B
-8%
2021
$4.8B
+15%
2020
$4.2B
+2%
2019
$4.1B
+10%
2018
$3.7B
+5%
2017
$3.6B
-7%
2016
$3.8B
-6%
2015
$4.1B
-5%
2014
$4.3B
+5%
2013
$4.1B
+21%
2012
$3.4B
+7%
2011
$3.2B
+9%
2010
$2.9B
+1%
2009
$2.9B
-5%
2008
$3.0B
-7%
2007
$3.3B
Recent Quarterly R&D Spend
Quarter
R&D Spend
Q1 2026
$1.7B
Q4 2025
$2.1B
Q3 2025
$1.9B
Q2 2025
$1.7B
Q1 2025
$1.5B
Q4 2024
$1.7B
Q3 2024
$1.4B
Q2 2024
$1.4B
Q1 2024
$1.3B
Q4 2023
$1.5B
Q3 2023
$1.1B
Q2 2023
$1.1B
Source: AMGN on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.